Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders
about
Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Infant siblings and the investigation of autism risk factorsMaternal conditions and perinatal characteristics associated with autism spectrum disorder and intellectual disabilityPopulation attributable fractions for three perinatal risk factors for autism spectrum disorders, 2002 and 2008 autism and developmental disabilities monitoring network.Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behaviorTerbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.Are Attributes of Pregnancy and the Delivery Room Experience Related to Development of Autism? A Review of the Perinatal and Labor Risk Factors and Autism.Resveratrol protects from lipopolysaccharide-induced inflammation in the uterus and prevents experimental preterm birth.Prenatal exposure to β2-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring.In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children.Benzo(a)pyrene triggers desensitization of β2-adrenergic pathway.Association between Beta-Sympathomimetic Tocolysis and Risk of Autistic Spectrum Disorders, Behavioural and Developmental Outcome in Toddlers.Meconium exposure and autism risk.Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.Beta-2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma.Developmental Neurotoxicity Resulting from Pharmacotherapy of Preterm Labor, Modeled In Vitro: Terbutaline and Dexamethasone, Separately and Together.Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort studyTerbutaline and Associated Risks for Neurodevelopmental Disorders
P2860
Q26741618-EF464EE6-2663-47FB-A583-ECBD15A138ECQ28388355-32571AF1-DBB1-476A-8AA8-3F160D97BCB7Q34544456-0D002B7D-4C0D-4664-B2F7-A0AD8410E845Q36036127-29E1F03F-96EA-490F-8C29-752F165A3D11Q36089383-4842BD2A-CFAC-425A-8FF7-2041197A8868Q36381363-540032CF-137E-4169-93F5-0A8D48C131FCQ36979990-71181598-D54B-4FF3-B30D-15B909CE3D37Q38623566-AE8943D8-0006-4B7A-989B-D47F364B9E0BQ40236964-F5903A87-0BD4-4BA8-B9E3-E53B9EF79203Q40341694-0DAE5502-11E1-42AE-BE4F-0378BA493494Q42206946-79D30CAE-9A2B-483D-A76E-27AF69EED211Q43281049-134E5AD7-4E20-4E49-98B1-66706E4CF416Q46321142-A30D1B04-B0AB-469F-A3F8-6D7CAFAB54D1Q47942709-9C9D9989-C628-44B8-85E2-B2F74E7C249BQ48003317-B6E8E123-A19B-4463-B4A1-A7B99F3B1EA6Q50420065-788091CD-5902-4F58-95C6-CA75A499F335Q58775160-ECCA124C-65CD-4EE1-A80C-71D13210E0FAQ59035957-85EAB99A-0715-4B04-8039-D466D8906D6E
P2860
Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@ast
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@en
type
label
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@ast
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@en
prefLabel
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@ast
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@en
P2093
P2860
P1476
Prenatal exposure to β2-adrene ...... k of autism spectrum disorders
@en
P2093
Andrew W Zimmerman
Craig Newschaffer
Marilyn Matevia
Susan L Connors
Yinge Qian
P2860
P2888
P304
P356
10.1007/S11689-011-9093-4
P50
P577
2011-08-27T00:00:00Z